BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

BURRELL INTERNATIONAL GROUP (ON BEHALF OF… — Receipts Report

LD-2 disclosure · 4th Quarter - Report

BURRELL INTERNATIONAL GROUP (ON BEHALF OF AMO PHARMA)

via TRUSYNERGY

4th Quarter (Oct 1 - Dec 31) · 2025Posted Jan 9, 2026Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: BURRELL INTERNATIONAL GROUP (ON BEHALF OF AMO PHARMA)
Description: Life Sciences R&D
Location: United Kingdom

Registrant

Firm: TRUSYNERGY
Location: Berwyn, Pennsylvania, United States of America

Lobbying activities

1 issue

Health Issues
Clinical trial guidance for ultra-rare and rare diseases.
LobbyistsMARK LENKER
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.